Cargando…

Systematic Review of the Relationship between Acute and Late Gastrointestinal Toxicity after Radiotherapy for Prostate Cancer

A small but meaningful percentage of men who are treated with external beam radiation therapy for prostate cancer will develop late gastrointestinal toxicity. While numerous strategies to prevent gastrointestinal injury have been studied, clinical trials concentrating on late toxicity have been diff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peach, Matthew Sean, Showalter, Timothy N., Ohri, Nitin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677238/ https://www.ncbi.nlm.nih.gov/pubmed/26697225 http://dx.doi.org/10.1155/2015/624736

Ejemplares similares

Effect of patient thickness on acute gastrointestinal toxicities following radiotherapy for prostate cancer
por: Pisani, Robert, et al.
Publicado: (2021)

Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
por: Heemsbergen, Wilma D., et al.
Publicado: (2020)

Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
por: D’Avino, Vittoria, et al.
Publicado: (2015)

Advances in Radiotherapy for Prostate Cancer Treatment
por: Podder, Tarun, et al.
Publicado: (2016)

Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis
por: Sinzabakira, F., et al.
Publicado: (2023)

Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma
por: Sanguineti, G, et al.
Publicado: (2002)

Late Gastrointestinal Tolerance After Prostate Radiotherapy: Is the Anal Canal the Culprit? A Narrative Critical Review
por: Sargos, Paul, et al.
Publicado: (2021)

Late Gastrointestinal Toxicity After Dose-Escalated Conformal Radiotherapy for Early Prostate Cancer: Results From the UK Medical Research Council RT01 Trial (ISRCTN47772397)
por: Syndikus, Isabel, et al.
Publicado: (2010)

Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy
por: Kerns, Sarah L, et al.
Publicado: (2019)

Predictive modelling for late rectal and urinary toxicities after prostate radiotherapy using planned and delivered dose
por: Ong, Ashley Li Kuan, et al.
Publicado: (2022)

Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity
por: Deantonio, Letizia, et al.
Publicado: (2010)

Optimizing parametrial aperture design utilizing HDR brachytherapy isodose distribution
por: Chapman, Katherine L., et al.
Publicado: (2013)

Radiotherapy Dosing for Locally Advanced Non-Small Cell Lung Carcinoma: “MTD” or “ALARA”?
por: Ohri, Nitin
Publicado: (2017)

Radiotherapy for inoperable Merkel cell carcinoma: a systematic review and pooled analysis
por: Patel, Parth, et al.
Publicado: (2018)

Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer
por: Ferreira, M.R., et al.
Publicado: (2019)

Prostate Cancer Radiotherapy: Increased Biochemical Control and Late Toxicity in Men With Medication Allergies
por: Turchan, William Tyler, et al.
Publicado: (2020)

Predicting Radiotherapy Impact on Late Bladder Toxicity in Prostate Cancer Patients: An Observational Study
por: Catucci, Francesco, et al.
Publicado: (2021)

Clinical risk factors for late intestinal toxicity after radiotherapy: a systematic review protocol
por: Qin, Qiyuan, et al.
Publicado: (2013)

Biological-effective versus conventional dose volume histograms correlated with late genitourinary and gastrointestinal toxicity after external beam radiotherapy for prostate cancer: a matched pair analysis
por: Jani, Ashesh B, et al.
Publicado: (2003)

Cardiac toxicity in patients with lung cancer receiving thoracic radiotherapy and immunotherapy
por: Son, Christine, et al.
Publicado: (2023)

Dose-volume analysis of planned versus accumulated dose as a predictor for late gastrointestinal toxicity in men receiving radiotherapy for high-risk prostate cancer
por: Ong, Ashley L.K, et al.
Publicado: (2022)

Impact of diabetes on gastrointestinal and urinary toxicity after radiotherapy for gynecologic malignancy
por: Özkan, Emine Elif, et al.
Publicado: (2019)

Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
por: Cella, Laura, et al.
Publicado: (2013)

Dosimetric correlation of acute and late toxicities in high-risk prostate cancer patients treated with three-dimensional conformal radiotherapy followed by intensity modulated radiotherapy boost
por: Kapoor, Rakesh, et al.
Publicado: (2016)

Dose-volume analysis of predictors for acute anal toxicity after radiotherapy in prostate cancer patients
por: Peng, Xingsi, et al.
Publicado: (2019)

Improving Patients’ Life Quality after Radiotherapy Treatment by Predicting Late Toxicities
por: Lapierre, Ariane, et al.
Publicado: (2022)

Can Anorectal Manometry Findings Predict Subsequent Late Gastrointestinal Radiation Toxicity in Prostate Cancer Patients?
por: Choi, Yunseon, et al.
Publicado: (2016)

Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
por: Thomson, David, et al.
Publicado: (2012)

The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B Study
por: Ratnakumaran, Ragu, et al.
Publicado: (2023)

Radiotherapy in elderly patients with breast cancer: a literature review of acute and late toxicity
por: Zamagni, Alice, et al.
Publicado: (2020)

Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer
por: Kerns, Sarah L., et al.
Publicado: (2016)

Long-Term (10-Year) Gastrointestinal and Genitourinary Toxicity after Treatment with External Beam Radiotherapy, Radical Prostatectomy, or Brachytherapy for Prostate Cancer
por: Hunter, Grant K., et al.
Publicado: (2012)

Impact of treatment planning and delivery factors on gastrointestinal toxicity: an analysis of data from the RADAR prostate radiotherapy trial
por: Yahya, Noorazrul, et al.
Publicado: (2014)

Comparison of chronic gastrointestinal and genitourinary toxicities between brachytherapy and external beam radiotherapy for patients with prostate cancer: A systematic review and meta-analysis
por: Li, Xuanzhe, et al.
Publicado: (2023)

Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy
por: Gill, Suki, et al.
Publicado: (2011)

Long-Term Outcomes of Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Relapse after Definitive Radiotherapy for Prostate Cancer: Patterns of Failure and Association between Volume of Irradiation and Late Toxicity
por: Miszczyk, Marcin, et al.
Publicado: (2023)

Efficacy and Toxicity of Whole Pelvic Radiotherapy Versus Prostate-Only Radiotherapy in Localized Prostate Cancer: A Systematic Review and Meta-Analysis
por: Wang, Shilin, et al.
Publicado: (2022)

High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients
por: Lips, Irene M, et al.
Publicado: (2008)

Predictors for late genitourinary toxicity in men receiving radiotherapy for high-risk prostate cancer using planned and accumulated dose
por: Li Kuan Ong, Ashley, et al.
Publicado: (2023)

Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a double-blinded, multicenter, phase II randomized controlled trial
por: Kim, Julian O., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k8rrhf670bqrkvm6l29dhu1ooj